{"id":"W2138167941","doi":"10.1097/ccm.0b013e3181b07b78","title":"Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis*","year":2009,"lang":"en","type":"article","venue":"Critical Care Medicine","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":226,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Eisai","keywords":"Medicine; Placebo; Internal medicine; Sepsis; Tolerability; Proinflammatory cytokine; Immunology; Adverse effect; Gastroenterology; Inflammation; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001882918,0.0001725475,0.0004545706,0.0001533914,0.00007150153,0.000004742698,0.0001303932,0.0002086517,0.0005035118],"category_scores_gemma":[0.0005309787,0.0001249784,0.00005013417,0.0001852545,0.0003757123,0.00009943538,0.00001508825,0.0002710716,0.00003202425],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005696943,"about_ca_system_score_gemma":0.00007744446,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002746503,"about_ca_topic_score_gemma":0.000005574505,"domain_scores_codex":[0.9986887,0.0002130649,0.0004665654,0.0002252136,0.0001034784,0.0003029854],"domain_scores_gemma":[0.9991943,0.0002187632,0.00006129353,0.0002486709,0.0002404482,0.00003653682],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5491234,0.006848567,0.006325935,0.0005649233,0.0001932698,0.00008259094,0.008876254,0.000001885163,0.2798861,0.002562005,0.02444484,0.1210902],"study_design_scores_gemma":[0.6945421,0.0899272,0.02756923,0.00139996,0.0004194397,0.0000470937,0.007497019,0.000003590337,0.09758902,0.0002021368,0.07982682,0.0009763594],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940896,0.001196267,0.00003875966,0.001975575,0.0009539743,0.0004712135,0.00003082006,0.00003243712,0.001211372],"genre_scores_gemma":[0.9989004,0.0000156718,0.00003728371,0.0003064123,0.0001173042,0.00001162169,0.0004764252,0.000009918955,0.0001250309],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1822971,"threshold_uncertainty_score":0.5513101,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009388701819016675,"score_gpt":0.284480393267328,"score_spread":0.2750916914483113,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}